Collaborations

Collaboration inked for the R&D of non-nuclear contrast media

Published in Health and Medicine Week, October 10th, 2005

Daiichi Pharmaceutical Co., Ltd., and GE Healthcare, a unit of General Electric Co. (GE), announced that Daiichi has executed a collaboration agreement for the research and development of non-nuclear contrast media with GE Healthcare.

Since Daiichi launched Omnipaque (Iohexol) in 1987, which is a contrast media for x-ray and computed tomography examinations, under license from GE Healthcare, Daiichi has marketed Omniscan, magnetic resonance imaging contrast media (launched in 1996) and Visipaque, an x-ray contrast media (launched in 2000) in Japan.

In addition to these products licensed, Daiichi has collaborated with GE Healthcare on the research and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-10-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry